Geoffrey M. Parker - Net Worth and Insider Trading

Geoffrey M. Parker Net Worth

The estimated net worth of Geoffrey M. Parker is at least $11 Million dollars as of 2024-11-05. Geoffrey M. Parker is the Director of ChemoCentryx Inc and owns about 129,603 shares of ChemoCentryx Inc (CCXI) stock worth over $7 Million. Geoffrey M. Parker is the CHIEF FINANCIAL OFFICER of Allogene Therapeutics Inc and owns about 819,590 shares of Allogene Therapeutics Inc (ALLO) stock worth over $2 Million. Geoffrey M. Parker is also the Director of Perrigo Co PLC and owns about 47,084 shares of Perrigo Co PLC (PRGO) stock worth over $1 Million. Besides these, Geoffrey M. Parker also holds Anacor Pharmaceuticals Inc (ANAC) , Sunesis Pharmaceuticals Inc (SNSS) , Better Therapeutics Inc (BTTX) , Tricida Inc (TCDAQ) . Details can be seen in Geoffrey M. Parker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Geoffrey M. Parker has not made any transactions after 2024-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Geoffrey M. Parker

To

Geoffrey M. Parker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Geoffrey M. Parker owns 9 companies in total, including Tricida Inc (TCDAQ) , ChemoCentryx Inc (CCXI) , and Perrigo Co PLC (PRGO) among others .

Click here to see the complete history of Geoffrey M. Parker’s form 4 insider trades.

Insider Ownership Summary of Geoffrey M. Parker

Ticker Comapny Transaction Date Type of Owner
TCDAQ Tricida Inc 2020-12-10 Chief Fin. Officer and Sr. VP
CCXI ChemoCentryx Inc 2021-03-05 director
PRGO Perrigo Co PLC 2023-06-13 director
LIMIT LIMIT 2017-05-31 director
LIMIT LIMIT 2015-03-23 Executive Vice President & CFO
LIMIT LIMIT 2016-03-23 director
LIMIT LIMIT 2023-07-27 director
LIMIT LIMIT 2021-10-28 director
LIMIT LIMIT 2024-01-30 CHIEF FINANCIAL OFFICER

Geoffrey M. Parker Latest Holdings Summary

Geoffrey M. Parker currently owns a total of 7 stocks. Among these stocks, Geoffrey M. Parker owns 129,603 shares of ChemoCentryx Inc (CCXI) as of March 5, 2021, with a value of $7 Million and a weighting of 59.23%. Geoffrey M. Parker owns 819,590 shares of Allogene Therapeutics Inc (ALLO) as of January 30, 2024, with a value of $2 Million and a weighting of 21.18%. Geoffrey M. Parker also owns 47,084 shares of Perrigo Co PLC (PRGO) as of June 13, 2023, with a value of $1 Million and a weighting of 10.44%. The other 4 stocks Anacor Pharmaceuticals Inc (ANAC) , Sunesis Pharmaceuticals Inc (SNSS) , Better Therapeutics Inc (BTTX) , Tricida Inc (TCDAQ) have a combined weighting of 9.14% among all his current holdings.

Latest Holdings of Geoffrey M. Parker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CCXI ChemoCentryx Inc 2021-03-05 129,603 51.99 6,738,060
ALLO Allogene Therapeutics Inc 2024-01-30 819,590 2.94 2,409,595
PRGO Perrigo Co PLC 2023-06-13 47,084 25.23 1,187,929
ANAC Anacor Pharmaceuticals Inc 2015-03-23 104,840 9.82 1,029,529
SNSS Sunesis Pharmaceuticals Inc 2016-12-09 1,878 5.32 9,991
BTTX Better Therapeutics Inc 2023-07-27 1,081,388 0.00 108
TCDAQ Tricida Inc 2020-12-10 250,837 0.00 3

Holding Weightings of Geoffrey M. Parker


Geoffrey M. Parker Form 4 Trading Tracker

According to the SEC Form 4 filings, Geoffrey M. Parker has made a total of 2 transactions in ChemoCentryx Inc (CCXI) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in ChemoCentryx Inc is the sale of 31,910 shares on March 5, 2021, which brought Geoffrey M. Parker around $2 Million.

According to the SEC Form 4 filings, Geoffrey M. Parker has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Allogene Therapeutics Inc is the acquisition of 190 shares on January 30, 2024, which cost Geoffrey M. Parker around $684.

According to the SEC Form 4 filings, Geoffrey M. Parker has made a total of 4 transactions in Perrigo Co PLC (PRGO) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Perrigo Co PLC is the acquisition of 10,000 shares on June 13, 2023, which cost Geoffrey M. Parker around $330,600.

More details on Geoffrey M. Parker's insider transactions can be found in the Insider Trading History of Geoffrey M. Parker table.

Insider Trading History of Geoffrey M. Parker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Geoffrey M. Parker Trading Performance

GuruFocus tracks the stock performance after each of Geoffrey M. Parker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geoffrey M. Parker is 5.89%. GuruFocus also compares Geoffrey M. Parker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geoffrey M. Parker within 3 months outperforms 17 times out of 40 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Geoffrey M. Parker's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Geoffrey M. Parker

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
19 out of 39 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.95 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.65 LIMIT LIMIT LIMIT LIMIT LIMIT

Geoffrey M. Parker Ownership Network

Ownership Network List of Geoffrey M. Parker

No Data

Ownership Network Relation of Geoffrey M. Parker

Insider Network Chart

Geoffrey M. Parker Owned Company Details

What does Tricida Inc do?

Who are the key executives at Tricida Inc?

Geoffrey M. Parker is the Chief Fin. Officer and Sr. VP of Tricida Inc. Other key executives at Tricida Inc include director & 10 percent owner Orbimed Advisors Llc , director & 10 percent owner David P Bonita , and 10 percent owner Venrock Healthcare Capital Partners Ii, L.p. .

Tricida Inc (TCDAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tricida Inc (TCDAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tricida Inc (TCDAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tricida Inc (TCDAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tricida Inc Insider Transactions

No Available Data

Geoffrey M. Parker Mailing Address

Above is the net worth, insider trading, and ownership report for Geoffrey M. Parker. You might contact Geoffrey M. Parker via mailing address: 15 Riordan Place, Menlo Park Ca 94025.